Literature DB >> 19937684

The reprogramming factors of human somatic cells are novel targets for human hepatocellular carcinoma therapy.

Hisashi Moriguchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19937684     DOI： 10.1002/hep.23287

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  3 in total

1.  Inhibition of mouse embryonic carcinoma cell growth by lidamycin through down-regulation of embryonic stem cell-like genes Oct4, Sox2 and Myc.

Authors:  Hong-Ying Zhen; Qi-Hua He; Yong-Zhan Zhen; Shu-Ling Wang; Yi-Nan Liu; Wei-Hua Wu; Xiao-Yan Zhang; Ai-Li Lu; Li Shen
Journal:  Invest New Drugs       Date:  2010-07-02       Impact factor: 3.850

2.  Krüppel-like Factor 4 Blocks Hepatocellular Carcinoma Dedifferentiation and Progression through Activation of Hepatocyte Nuclear Factor-6.

Authors:  Hongcheng Sun; Huamei Tang; Dacheng Xie; Zhiliang Jia; Zhenyu Ma; Daoyan Wei; Lopa Mishra; Yong Gao; Shaojiang Zheng; Keping Xie; Zhihai Peng
Journal:  Clin Cancer Res       Date:  2015-09-02       Impact factor: 12.531

3.  USP11 degrades KLF4 via its deubiquitinase activity in liver diseases.

Authors:  Heeyoung Yang; Daeui Park; Jeongho Ryu; Tamina Park
Journal:  J Cell Mol Med       Date:  2021-06-10       Impact factor: 5.310
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.